46 related articles for article (PubMed ID: 2967265)
1. Melphalan attenuates streptozotocin-induced diabetes in C57BL/6 and C3H3 mice.
Biener J; Flechner I; Laron Z
Isr J Med Sci; 1988 Mar; 24(3):190-1. PubMed ID: 2967265
[No Abstract] [Full Text] [Related]
2. Diabetes mellitus in mice induced by multiple subdiabetogenic doses of streptozotocin: age and sex dependence.
Kuttler B; Schneider E
Acta Biol Med Ger; 1982; 41(12):1199-1202. PubMed ID: 6231788
[TBL] [Abstract][Full Text] [Related]
3. Effect of cyclosporin A on low-dose streptozotocin diabetes in mice.
Kolb H; Oschilewski M; Schwab E; Oschilewski U; Kiesel U
Diabetes Res; 1985 Jul; 2(4):191-3. PubMed ID: 3910327
[TBL] [Abstract][Full Text] [Related]
4. Preventative effects of the flowers of Inula britannica on autoimmune diabetes in C57BL/KsJ mice induced by multiple low doses of streptozotocin.
Kobayashi T; Song QH; Hong T; Kitamura H; Cyong JC
Phytother Res; 2002 Jun; 16(4):377-82. PubMed ID: 12112297
[TBL] [Abstract][Full Text] [Related]
5. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
Sternesjö J; Welsh N; Sandler S
Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
[TBL] [Abstract][Full Text] [Related]
6. Genetic control of low-dose streptozotocin-induced autoimmune diabetes in mice.
Kiesel U; Falkenberg FW; Kolb H
J Immunol; 1983 Apr; 130(4):1719-22. PubMed ID: 6833751
[TBL] [Abstract][Full Text] [Related]
7. Ciamexon in the low dose streptozotocin induced diabetes of mice.
Linn T; Volkmann A; Germann H; Woehrle M; Bretzel RG; Bicker U; Federlin K
Diabetes Res; 1987 Nov; 6(3):113-7. PubMed ID: 3325216
[TBL] [Abstract][Full Text] [Related]
8. Expression and immune response to islet antigens following treatment with low doses of streptozotocin in H-2d mice.
Herold KC; Baumann E; Vezys V; Buckingham F
J Autoimmun; 1997 Feb; 10(1):17-25. PubMed ID: 9080296
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of streptozotocin and streptozotocin-induced diabetes mellitus on tumor metastases and growth in mice.
Arbogast BW; Berry DL; Chi DS
Anticancer Res; 1983; 3(6):361-6. PubMed ID: 6230983
[TBL] [Abstract][Full Text] [Related]
10. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
[TBL] [Abstract][Full Text] [Related]
11. Paraoxonase 1 (PON1) attenuates diabetes development in mice through its antioxidative properties.
Rozenberg O; Shiner M; Aviram M; Hayek T
Free Radic Biol Med; 2008 Jun; 44(11):1951-9. PubMed ID: 18358245
[TBL] [Abstract][Full Text] [Related]
12. Insulin attenuates formalin-induced nociceptive response in mice through a mechanism that is deranged by diabetes mellitus.
Takeshita N; Yamaguchi I
J Pharmacol Exp Ther; 1997 Apr; 281(1):315-21. PubMed ID: 9103512
[TBL] [Abstract][Full Text] [Related]
13. Plasma glucose and pancreatic insulin content in the early phase of streptozotocin-induced diabetes (preliminary results).
Hahn HJ; Hagen R; Knobloch C; Besch W
Acta Biol Med Ger; 1981; 40(1):83-5. PubMed ID: 6455026
[TBL] [Abstract][Full Text] [Related]
14. Insights into modeling streptozotocin-induced diabetes in ICR mice.
Dekel Y; Glucksam Y; Elron-Gross I; Margalit R
Lab Anim (NY); 2009 Feb; 38(2):55-60. PubMed ID: 19165193
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulation of streptozotocin-induced diabetes in mice by a lipopolysaccharide.
Flechner I; Muntefering H; Smadja Y; Laron Z
Diabetes Res; 1984 Nov; 1(4):231-2. PubMed ID: 6241545
[No Abstract] [Full Text] [Related]
16. Dominant negative 14-3-3 promotes cardiomyocyte apoptosis in early stage of type I diabetes mellitus through activation of JNK.
Gurusamy N; Watanabe K; Ma M; Zhang S; Muslin AJ; Kodama M; Aizawa Y
Biochem Biophys Res Commun; 2004 Jul; 320(3):773-80. PubMed ID: 15240115
[TBL] [Abstract][Full Text] [Related]
17. Analysis of 22 immunomodulatory substances for efficacy in low-dose streptozotocin-induced diabetes.
Kolb H; Oschilewski M; Oschilewski U; Schwab E; Moumé CM; Greulich B; Burkart V; Zielasek J; Kiesel U
Diabetes Res; 1987 Sep; 6(1):21-7. PubMed ID: 3319352
[TBL] [Abstract][Full Text] [Related]
18. [Protection against streptozotocin-induced diabetes by cholecystokinin-octapeptide in mice].
Zhu WY; Jin YS
Sheng Li Xue Bao; 1985 Dec; 37(6):539-44. PubMed ID: 2945255
[No Abstract] [Full Text] [Related]
19. [Study of dynamic changes of blood sugar and body signs in streptozotocin-induced diabetic animal models].
Yu CL; Zhu ZG; Lei LS
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jan; 28(1):132-3. PubMed ID: 18227045
[TBL] [Abstract][Full Text] [Related]
20. Effects of vaccination with heat shock proteins on streptozotocin induced diabetes in histidine decarboxylase knockout mice.
Szebeni A; Prohászka Z; Buzás E; Falus A; Kecskeméti V
Inflamm Res; 2008 Apr; 57(4):178-82. PubMed ID: 18351435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
